Click to copy
Press release content from Business Wire. The AP news staff was not involved in its creation.
Click to copy
PRESS RELEASE: Paid content from Business Wire
Press release content from Business Wire. The AP news staff was not involved in its creation.

Global Colorectal Cancer Market Review & Outlook (2017-2026) - ResearchAndMarkets.com

September 16, 2019

DUBLIN--(BUSINESS WIRE)--Sep 16, 2019--

The “Colorectal Cancer - Global Market Outlook (2017-2026)” report has been added to ResearchAndMarkets.com’s offering.

The Global Colorectal Cancer market accounted for $9.22 billion in 2017 and is expected to reach $13.01 billion by 2026 growing at a CAGR of 3.9% during the forecast period.

Introduction of new and improved therapies and drugs, the rising uptake of higher-priced branded therapies, and several initiatives by governments and private organizations are some of the factors fuelling the market growth. However, factors such as the reluctance toward colorectal cancer medications on the part of patients and a lack of awareness in many parts of the world will pose a threat to the growth of the overall market.

Based on therapies & drugs, the increasing awareness for treating colorectal cancer by chemotherapy and immunotherapy propels the industry growth during the forecast period.

By Geography, North America is a key region in the market and estimated to have a lucrative growth in terms of demand and revenue. This market is fueled by a number of factors, the primary one being greater prevalence of colorectal cancer.

Some of the key players profiled in the Colorectal Cancer market include Abbott Laboratories, Amgen, Clinical Genomics, EDP Biotech, Epigenomics, Hoffmann-La Roche, Novigenix, Quest Diagnostics, Sanofi, Siemens Healthineers and VolitionRX.

What the report offers:

Key Topics Covered

1 Executive Summary

2 Preface

3 Market Trend Analysis

3.1 Introduction

3.2 Drivers

3.3 Restraints

3.4 Opportunities

3.5 Threats

3.6 Product Analysis

3.7 Application Analysis

3.8 Emerging Markets

3.9 Futuristic Market Scenario

4 Porters Five Force Analysis

5 Global Colorectal Cancer Market, By Therapies & Drugs

5.1 Introduction

5.2 Chemo Therapy

5.2.1 Alkylating Agent - Oxaliplatin (Eloxatin)

5.2.2 Antimetabolites Capecitabine (Xeloda) Fluorouracil (Adrucil)

5.3 Immuno Therapy

5.3.1 Biologic Response Modifiers

5.3.2 Colony-Stimulating Factors

5.3.3 Monoclonal Antibodies Bevacizumab (Avastin) Cetuximab (Erbitux) Panitumumab (Vectibix)

5.3.4 Tumor Vaccines

5.4 Radiation Therapy

5.5 Surgery

5.6 Others Therapies & Drugs

6 Global Colorectal Cancer Market, By Testing & Diagnosis

6.1 Introduction

6.2 Immunochemistry

6.3 Macroscopy

6.4 Microscopy

6.5 Staging

6.6 Tumor Budding

7 Global Colorectal Cancer Market, By Procedure

7.1 Introduction

7.2 Biopsy

7.3 Colostomy

7.4 Magnetic Resonance Imaging (MRI)

7.5 Mammography

7.6 Sigmoidoscopy

8 Global Colorectal Cancer Market, By Product

8.1 Introduction

8.2 Flow Cytometry

8.3 In Situ Hybridization

8.4 Microarrays

8.5 Next-Generation Sequencing

8.6 Targeted Therapy

9 Global Colorectal Cancer Market, By Application

9.1 Introduction

9.2 Hospitals and Clinics

9.3 Other Applications

10 Global Colorectal Cancer Market, By Geography

10.1 Introduction

10.2 North America

10.3 Europe

10.4 Asia Pacific

10.5 South-America

10.6 Middle East & Africa

11 Key Developments

11.1 Agreements, Partnerships, Collaborations and Joint Ventures

11.2 Acquisitions & Mergers

11.3 New Product Launch

11.4 Expansions

11.5 Other Key Strategies

12 Company Profiling

12.1 Abbott Laboratories

12.2 Amgen Inc.

12.3 Clinical Genomics

12.4 EDP Biotech

12.5 Epigenomics AG

12.6 Hoffmann-La Roche AG

12.7 Novigenix S.A.

12.8 Quest Diagnostics

12.9 Sanofi S.A.

12.10 Siemens Healthineers

12.11 VolitionRX

For more information about this report visit https://www.researchandmarkets.com/r/8pmjx8

View source version on businesswire.com:https://www.businesswire.com/news/home/20190916005328/en/

CONTACT: ResearchAndMarkets.com

Laura Wood, Senior Press Manager


For E.S.T Office Hours Call 1-917-300-0470

For U.S./CAN Toll Free Call 1-800-526-8630

For GMT Office Hours Call +353-1-416-8900



SOURCE: Research and Markets

Copyright Business Wire 2019.

PUB: 09/16/2019 03:41 AM/DISC: 09/16/2019 03:41 AM


All contents © copyright 2019 The Associated Press. All rights reserved.